Boston Scientific Return on Tangible Equity 2012-2026 | BSX
Current and historical return on tangible equity values for Boston Scientific (BSX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Boston Scientific Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-06-30 | $3.68B | $-0.61B | -599.27% |
| 2026-03-31 | $3.57B | $-1.19B | -300.21% |
| 2025-12-31 | $2.90B | $-1.68B | -172.55% |
| 2025-09-30 | $2.79B | $-1.92B | -145.82% |
| 2025-06-30 | $2.51B | $-1.44B | -174.44% |
| 2025-03-31 | $2.03B | $-0.57B | -358.69% |
| 2024-12-31 | $1.85B | $-0.21B | -884.49% |
| 2024-09-30 | $1.79B | $0.02B | 9950.00% |
| 2024-06-30 | $1.83B | $-0.11B | -1720.47% |
| 2024-03-31 | $1.77B | $-0.61B | -287.34% |
| 2023-12-31 | $1.57B | $-0.91B | -172.29% |
| 2023-09-30 | $1.19B | $-1.01B | -118.10% |
| 2023-06-30 | $0.86B | $-1.24B | -69.13% |
| 2023-03-31 | $0.85B | $-1.43B | -59.09% |
| 2022-12-31 | $0.64B | $-1.82B | -35.20% |
| 2022-09-30 | $0.60B | $-1.88B | -31.75% |
| 2022-06-30 | $0.83B | $-1.96B | -42.24% |
| 2022-03-31 | $0.76B | $-1.65B | -45.83% |
| 2021-12-31 | $0.99B | $-1.23B | -79.87% |
| 2021-09-30 | $1.10B | $-1.00B | -110.33% |
| 2021-06-30 | $0.53B | $-0.94B | -55.78% |
| 2021-03-31 | $0.20B | $-1.17B | -17.12% |
| 2020-12-31 | $-0.12B | $-1.81B | 6.35% |
| 2020-09-30 | $3.69B | $-2.72B | -135.39% |
| 2020-06-30 | $3.98B | $-4.48B | -88.90% |
| 2020-03-31 | $4.29B | $-5.44B | -78.75% |
| 2019-12-31 | $4.70B | $-5.87B | -80.06% |
| 2019-09-30 | $1.09B | $-6.21B | -17.54% |
| 2019-06-30 | $1.40B | $-5.52B | -25.31% |
| 2019-03-31 | $1.80B | $-5.50B | -32.70% |
| 2018-12-31 | $1.67B | $-5.56B | -30.04% |
| 2018-09-30 | $0.67B | $-5.63B | -11.90% |
| 2018-06-30 | $0.52B | $-5.50B | -9.47% |
| 2018-03-31 | $0.11B | $-5.53B | -2.02% |
| 2017-12-31 | $0.10B | $-5.46B | -1.91% |
| 2017-09-30 | $0.84B | $-5.46B | -15.45% |
| 2017-06-30 | $0.79B | $-5.65B | -13.94% |
| 2017-03-31 | $0.44B | $-5.81B | -7.49% |
| 2016-12-31 | $0.35B | $-5.99B | -5.80% |
| 2016-09-30 | $0.08B | $-6.12B | -1.32% |
| 2016-06-30 | $-0.35B | $-6.23B | 5.54% |
| 2016-03-31 | $-0.04B | $-5.88B | 0.61% |
| 2015-12-31 | $-0.24B | $-5.58B | 4.28% |
| 2015-09-30 | $-0.40B | $-5.26B | 7.54% |
| 2015-06-30 | $-0.16B | $-4.92B | 3.15% |
| 2015-03-31 | $-0.25B | $-4.93B | 5.13% |
| 2014-12-31 | $-0.12B | $-4.95B | 2.40% |
| 2014-09-30 | $0.29B | $-4.96B | -5.80% |
| 2014-06-30 | $0.24B | $-4.96B | -4.84% |
| 2014-03-31 | $0.37B | $-4.99B | -7.33% |
| 2013-12-31 | $-0.12B | $-5.06B | 2.39% |
| 2013-09-30 | $-0.17B | $-5.13B | 3.27% |
| 2013-06-30 | $-0.83B | $-5.16B | 16.02% |
| 2013-03-31 | $-4.54B | $-5.17B | 87.79% |
| 2012-12-31 | $-4.07B | $-5.05B | 80.61% |
| 2012-09-30 | $-4.02B | $-4.92B | 81.77% |
| 2012-06-30 | $-3.22B | $-4.86B | 66.19% |
| 2012-03-31 | $0.51B | $-4.84B | -10.51% |
| 2011-12-31 | $0.44B | $-4.95B | -8.92% |
| 2011-09-30 | $0.57B | $-5.03B | -11.33% |
| 2011-06-30 | $0.62B | $-5.29B | -11.68% |
| 2011-03-31 | $0.57B | $-5.59B | -10.19% |
| 2010-12-31 | $-1.07B | $-5.88B | 18.13% |
| 2010-09-30 | $-2.38B | $-6.14B | 38.70% |
| 2010-06-30 | $-2.66B | $-6.18B | 43.07% |
| 2010-03-31 | $-2.60B | $-6.15B | 42.29% |
| 2009-12-31 | $-1.03B | $-6.14B | 16.70% |
| 2009-09-30 | $-2.33B | $-6.18B | 37.69% |
| 2009-06-30 | $-2.31B | $-6.40B | 36.12% |
| 2009-03-31 | $-2.37B | $-6.68B | 35.48% |
| 2008-12-31 | $-2.04B | $-7.00B | 29.11% |
| 2008-09-30 | $-0.11B | $-7.36B | 1.52% |
| 2008-06-30 | $-0.31B | $-7.84B | 3.95% |
| 2008-03-31 | $-0.29B | $-8.06B | 3.63% |
| 2007-12-31 | $-0.50B | $-8.29B | 5.97% |
| 2007-09-30 | $0.24B | $-8.07B | -2.98% |
| 2007-06-30 | $0.59B | $-8.01B | -7.34% |
| 2007-03-31 | $-3.79B | $-8.22B | 46.09% |
| 2006-12-31 | $-3.58B | $-5.89B | 60.78% |
| 2006-09-30 | $-3.52B | $-3.98B | 88.49% |
| 2006-06-30 | $-3.87B | $-1.75B | 220.35% |
| 2006-03-31 | $0.60B | $0.62B | 96.51% |
| 2005-12-31 | $0.63B | $0.65B | 97.29% |
| 2005-09-30 | $0.59B | $0.68B | 86.91% |
| 2005-06-30 | $1.12B | $0.76B | 147.64% |
| 2005-03-31 | $1.23B | $0.69B | 178.26% |
| 2004-12-31 | $1.06B | $0.62B | 170.74% |
| 2004-09-30 | $0.90B | $0.55B | 163.70% |
| 2004-06-30 | $0.77B | $0.41B | 188.47% |
| 2004-03-31 | $0.57B | $0.37B | 154.72% |
| 2003-12-31 | $0.47B | $0.19B | 250.07% |
| 2003-09-30 | $0.44B | $0.11B | 387.67% |
| 2003-06-30 | $0.48B | $0.12B | 412.10% |
| 2003-03-31 | $0.39B | $0.04B | 963.98% |
| 2002-12-31 | $0.37B | $0.05B | 769.07% |
| 2002-09-30 | $0.33B | $0.01B | 2960.00% |
| 2002-06-30 | $0.23B | $-0.04B | -560.98% |
| 2002-03-31 | $0.03B | $-0.04B | -82.50% |
| 2001-12-31 | $-0.05B | $0.01B | -526.83% |
| 2001-09-30 | $-0.06B | $0.09B | -66.67% |
| 2001-06-30 | $-0.03B | $0.17B | -18.55% |
| 2001-03-31 | $0.26B | $0.23B | 112.57% |
| 2000-12-31 | $0.37B | $0.18B | 204.38% |
| 2000-09-30 | $0.42B | $0.12B | 362.07% |
| 2000-06-30 | $0.39B | $0.06B | 684.21% |
| 2000-03-31 | $0.38B | $-0.01B | -3506.98% |
| 1999-12-31 | $0.37B | $-0.25B | -151.58% |
| 1999-09-30 | $0.33B | $-0.49B | -67.85% |
| 1999-06-30 | $-0.18B | $-0.76B | 24.07% |
| 1999-03-31 | $-0.23B | $-0.52B | 43.65% |
| 1998-12-31 | $-0.27B | $-0.11B | 237.14% |
| 1998-09-30 | $-0.34B | $0.31B | -111.66% |
| 1998-06-30 | $0.20B | $0.75B | 27.04% |
| 1998-03-31 | $0.10B | $0.69B | 14.81% |
| 1997-12-31 | $0.11B | $0.67B | 16.65% |
| 1997-09-30 | $0.19B | $0.65B | 29.67% |
| 1997-06-30 | $0.18B | $0.61B | 29.87% |
| 1997-03-31 | $0.24B | $0.56B | 42.33% |
| 1996-12-31 | $0.17B | $0.53B | 31.97% |
| 1996-09-30 | $0.06B | $0.53B | 12.14% |
| 1996-06-30 | $0.05B | $0.52B | 8.60% |
| 1996-03-31 | $0.07B | $0.52B | 12.87% |
| 1995-12-31 | $0.00B | $0.49B | -0.20% |
| 1995-09-30 | $0.05B | $0.41B | 11.93% |
| 1995-06-30 | $0.02B | $0.36B | 5.63% |
| 1995-03-31 | $0.00B | $0.31B | 0.97% |
| 1994-12-31 | $0.06B | $0.28B | 21.47% |
| 1994-09-30 | $0.06B | $0.26B | 21.88% |
| 1994-06-30 | $0.05B | $0.24B | 22.01% |
| 1994-03-31 | $0.04B | $0.23B | 17.58% |
| 1993-12-31 | $0.07B | $0.24B | 28.96% |
| 1993-09-30 | $0.07B | $0.24B | 27.00% |
| 1993-06-30 | $0.06B | $0.24B | 26.22% |
| 1993-03-31 | $0.06B | $0.23B | 25.24% |
| 1992-12-31 | $0.06B | $0.17B | 33.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $65.288B | $20.074B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |